Lewes, DE -- (SBWIRE) -- 08/19/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: SourcingLink.net, Inc.(OTCMKTS:SNET), Nestle SA Reg Shs. Ser. B Spons (ADR)(OTCMKTS:NSRGY), Medical Marijuana Inc(OTCMKTS:MJNA), Arch Therapeutics Inc(OTCBB:ARTH).
SourcingLink.net, Inc.(OTCMKTS:SNET) ended lower -34.48% and complete the day at $0.190. The total number of shares changed hands during the day was 4.06 million. After opening at $0.37, the stock hit as high as $0.38. However, it traded between $0.03 and 1.15 over the last twelve months.
SourcingLink.net, Inc. was involved in developing and deploying merchandise-sourcing solutions for the retail industry prior to its operating assets sale in March 2004.
Has SNET Found The Bottom and Ready To Move Up? Find Out Here
Nestle SA Reg Shs. Ser. B Spons (ADR)(OTCMKTS:NSRGY) closed yesterday at $66.90, a -0.83% decrease. Around 515,209 shares were traded, low from an-average trading volume of 750,428 shares. The company is now valued at around $271.55 billion.
Nestle SA is a Switzerland-based holding company of the Nestle Group (the Group) and is principally engaged in the development and production of food and beverage. The Group manages its Food and Beverages business through three geographic zones (Zone Europe, Zone Americas and Zone Asia, Oceania and Africa) and globally for Nestle Waters, Nestle Nutrition and Other Food and Beverages (Others).
Has NSRGY Found The Bottom And Ready To Gain Momentum? Find Out Here
Medical Marijuana Inc(OTCMKTS:MJNA) moved +2.79 percent higher at $0.162 and traded between $0.16 and $0.17 after opening the day at $0.16. Its performance over the last five days remained -6.69%, which stands at 30.04% for a month. Going back further than one month, 1-year performance after recent close was 60.3%.
Medical Marijuana Inc. (MJNA) is the publicly held company vested in the medical marijuana and industrial hemp markets. It is comprised of a diversified portfolio of products, services, technology and businesses solely focused on the cannabis and hemp industries.
For How Long MJNA Gloss will Attract Investors? Find out via this report
Arch Therapeutics Inc(OTCBB:ARTH) shares rose, gaining +9.76 percent to close at $0.505. The stock is down around -50.01% this year and -50.01% for the last 12 months. Around 1.39 million shares changed hands yesterday, lower from an-average trading volume of 2.18 million shares.
Arch Therapeutics, Inc. (Arch), formerly Almah, Inc., operates as a life science company developing polymers containing peptides intended to form gel-like barriers over wounds to stop or control bleeding. Arch is a medical device company offering an approach to the rapid cessation of bleeding (hemostasis) and control of fluid leakage (sealant) during surgery and trauma care. Arch’s products are in preclinical development.
Why Should Investors Buy ARTH After The Recent Gain?Just Go Here and Find Out
LeadingStockAlertsis a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/